Abstract:We paid attentions on recently published paper by Lei and colleagues [ [1] Lei Y. Yang G. Hu L. et al. Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress. Int. J. Cardiol. 2017 Sep 15; 243: 413-420 Abstract Full Text Full Text PDF PubMed Scopus (53) Google Scholar ]. The authors highlighted that DDP-4 inhibition with anagliptin contributed to atherosclerotic resistance. Intriguingly, the protective roles of DPP-4 inhibition during high glucose(HG)-/oscillating glucose(OG)-caused metabolic memory (MM) expanded their therapeutic effects [ 2 Sala L.L. Genovese S. Ceriello A. Effect of vildagliptin, compared to sitagliptin, on the onset of hyperglycemia-induced metabolic memory in human umbilical vein endothelial cells. Cardiovasc. Pharm. Open Access. 2017; 6: 203https://doi.org/10.4172/2329-6607.1000203 Crossref Google Scholar , 3 Pujadas G. De Nigris V. Prattichizzo F. et al. The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory. Endocrine. 2016; 56: 509-520 Crossref PubMed Scopus (43) Google Scholar ]. It has been commonly indicated that early HG or OG was remembered despite tight glucose control on micro-/macro-vasculature that referred to MM [ 4 Schisano B. Tripathi G. McGee K. et al. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia. 2011; 54: 1219-1226 Crossref PubMed Scopus (132) Google Scholar , 5 Chen J. Zhang J. Yang J. et al. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats. Atherosclerosis. 2017; 257: 152-163 Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar ], and the mechanisms complied with persistent epigenetic modification [ 4 Schisano B. Tripathi G. McGee K. et al. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia. 2011; 54: 1219-1226 Crossref PubMed Scopus (132) Google Scholar , 5 Chen J. Zhang J. Yang J. et al. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats. Atherosclerosis. 2017; 257: 152-163 Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar ]. Although our prior studies suggested that targeting histone demethylase KDM3A might limit MM-induced constant vascular remodeling [ [5] Chen J. Zhang J. Yang J. et al. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats. Atherosclerosis. 2017; 257: 152-163 Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar ], there existed great differences to transfer above achievements onto clinical trials. Response to letter “DPP-4 inhibition as a therapeutic strategy to ameliorate diabetic metabolic memory”International Journal of CardiologyVol. 256PreviewRecently, we have published our work entitled “Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in apolipoprotein E-deficient mice under chronic stress” [1]. In our study, anagliptin ameliorated harmful changes in plasma dipeptidyl peptidase-4 (DPP4), glucagon-like protein-1 (GLP-1), and adiponectin and decreased the parameters of inflammatory response and oxidative stress and proteolysis in the plaques of the stressed mice, suggesting that the ability of DPP4 inhibition to lessen over-activated inflammation, oxidative stress production and proteolysis may have a salutary effect on vascular damage under stress conditions through GLP-1-mediated adiponectin production in apolipoprotein E-deficient (ApoE−/−) mice fed high fat-diet. Full-Text PDF

Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging

Dipeptidyl Peptidase IV(DPP IV): a Novel Emerging Target for the Treatment of Type 2 Diabetes

The protective role of DPP4 inhibitors in atherosclerosis

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Progress in the investigation of cardiovascular protective effects of DPP-4 inhibitors

The Role of SGLT2 Inhibitors in Vascular Aging

DPP-4 Inhibition As a Therapeutic Strategy to Ameliorate Diabetic Metabolic Memory.

DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice

DPP-4/GLP-1 Axis as a Potential Therapeutic Target in Chronic Stress-related Vascular Aging and Atherosclerosis

The Role and Mechanism of Vascular Aging in Geriatric Vascular Diseases

Effects of DPP-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetic Patients

Endogenous Vasoactive Peptides and Vascular Aging-Related Diseases

DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2–COX-2–TP Axis and NLRP3 Inflammasome Activation

DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs

Targeting Epigenetic Mechanisms in Vascular Aging

Dose rectification of an imbalance between DPP4 and GLP‐1 ameliorates chronic stress‐related vascular aging and atherosclerosis?

SGLT2 Inhibitors in Aging-Related Cardiovascular Disease: A Review of Potential Mechanisms

Dose rectification of an unbalance between DPP4 and GLP-1 ameliorates chronic stress-related vascular aging and atherosclerosis?

The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications

Emerging Roles of Dipeptidyl Peptidase 4 Inhibitors: Anti-Inflammatory and Immunomodulatory Effect and Its Application in Diabetes Mellitus.

The Regulatory Role of DPP4 in Atherosclerotic Disease